You are here: Industry Insights > glaucoma

News List

Latanoprost and Intraocular Pressure Relief David Orchard-Webb
October 09, 2024
In this article, we will look at the mechanism of action, clinical uses, and common concerns for Latanoprost as a therapy for excessive IOP.
Ophthalmic Company Implandata Awarded as Top 12 Healthcare Innovator at Medica, World Forum for Medicine B3Cnewswire
October 20, 2021
Implandata Ophthalmic Products, a digital health eye care company with offices in Germany and San Diego, California has been selected as Top 12 Health Techpreneur at the Healthcare Innovation World Cup at Medica...
iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients prnasia
July 15, 2021
iSTAR Medical announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to start a pivotal trial with MINIjectTM.
Arctic Vision Joins Forces with the University of Hong Kong, S.A.R., China Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease firstwordpharma
July 05, 2021
Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today a new research collaboration with Prof.
SPARC declares positive results from Phase 3 clinical trial of PDP-716 to treat open-angle glaucoma or ocular hypertension expresspharma
May 14, 2021
Sun Pharma Advanced Research Company (SPARC) reported positive top-line results from its Phase 3 trial (CLR_16_33) for its investigational drug, PDP-716 ophthalmic suspension, for the treatment of open angle glaucoma or ocular hypertension.
Drug-eluting contact lens shows potential in first-in-human study europeanpharmaceuticalreview
March 18, 2021
The LLT-BMT1 drug releasing contact lens was safe, well tolerated and may have reduced the incidence of hyperaemia in an early glaucoma trial.
Indoco launches Brinzolamide Ophthalmic Suspension 1% in US by Teva Pharma expresspharma
March 10, 2021
Indoco Remedies announces the launch of Brinzolamide Ophthalmic Suspension 1% in the US, the first generic version of AZOPT by Teva Pharmaceuticals. The product is developed and manufactured by Indoco Remedies for TEVA at its facility in Goa.
ENTOD Pharma launches #FreeGlaucomaTherapyforLife Campaign expresspharma
March 09, 2021
ENTOD Pharmaceuticals announced its commitment to offer financial support to 250 under-privileged glaucoma patients to ensure they have lifetime access to critical glaucoma medicines.
Exposure to Ambient Air Pollution May Increase Risk for Glaucoma drugs
December 19, 2019
Exposure to ambient air pollution is associated with a higher risk for glaucoma and adverse structural characteristics of the disease ...
Netarsudil Lowers IOP in Glaucoma, Ocular Hypertension drugs
September 02, 2019
Netarsudil ophthalmic solution (0.02 percent; once daily) significantly reduced mean intraocular pressure (IOP) among patients with open-angle glaucoma...

Previous page 1 2 3 Next page